Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Ononin inhibits triple-negative breast cancer lung metastasis by targeting the EGFR-mediated PI3K/Akt/mTOR pathway
Kumar Ganesan, Cong Xu, Jianming Wu, et al.
Science China Life Sciences (2024) Vol. 67, Iss. 9, pp. 1849-1866
Closed Access | Times Cited: 32

Showing 1-25 of 32 citing articles:

A new peptide inhibitor of C1QBP exhibits potent anti‐tumour activity against triple negative breast cancer by impairing mitochondrial function and suppressing homologous recombination repair
Xingxing Li, Yue Wu, Min Zhang, et al.
Clinical and Translational Medicine (2025) Vol. 15, Iss. 1
Open Access
FASN inhibition shows the potential for enhancing radiotherapy outcomes by targeting glycolysis, AKT, and ERK pathways in breast cancer
Ching-I Chen, Deng-Yu Kuo, Hui-Yen Chuang
International Journal of Radiation Biology (2025), pp. 1-12
Open Access
Pseudostellaria heterophylla (Miq.) Pax, a Traditional Folk Medicine, Ameliorates Colorectal Cancer by Remodeling the Tumor Immune Microenvironment
Gui Yang, Hui Wu, Heng Fan
Journal of Ethnopharmacology (2025) Vol. 342, pp. 119362-119362
Closed Access
Anticancer Effects of MAPK6 siRNA‐Loaded PLGA Nanoparticles in the Treatment of Breast Cancer
Ceyhun Toruntay, Fatma Şayan Poyraz, Seda Süsgün, et al.
Journal of Cellular and Molecular Medicine (2025) Vol. 29, Iss. 2
Open Access
Improved Efficacy of Triple‐Negative Breast Cancer Immunotherapy via Hydrogel‐Based Co‐Delivery of CAR‐T Cells and Mitophagy Agonist
Guodong Li, Ruoxin Du, Donghui Wang, et al.
Advanced Science (2025)
Open Access
An update on promising and emerging protein kinase B/AKT inhibitors for breast cancer
Riccardo Asnaghi, Gabriele Antonarelli, Elena Battaiotto, et al.
Expert Opinion on Pharmacotherapy (2025)
Open Access
Didymin Inhibits Proliferation and Induces Apoptosis in Gastric Cancer Cells by Modulating the PI3K/Akt Pathway
Tong Zhang, Bin Xu
Nutrition and Cancer (2025), pp. 1-16
Closed Access
Novel Strategy of Antibody Affinity Maturation and Enhancement of Nucleolin‐Mediated Antibody‐Dependent Cellular Cytotoxicity Against Triple‐Negative Breast Cancer
Rita Ribeiro, Jorge M. B. Vítor, Anastasiya Voronovska, et al.
Biotechnology Journal (2025) Vol. 20, Iss. 1
Closed Access
Smurf2 Suppresses Proliferation and Cell Cycle of Triple‐Negative Breast Cancer Cells by Promoting the Polyubiquitination and Degradation of RPL35A
Wei Siyu, Yuying Liu, Zhihao Wang, et al.
Journal of Cellular and Molecular Medicine (2025) Vol. 29, Iss. 2
Open Access
Sotorasib resistance triggers epithelial-mesenchymal transition and activates AKT and P38-mediated signaling
Raquel Megid, Guilherme Ribeiro, Izabela Natália Faria Gomes, et al.
Frontiers in Molecular Biosciences (2025) Vol. 12
Open Access
Nanoconjugate Carrying pH-Responsive Transferrin Receptor-Targeted Hesperetin Triggers Triple-Negative Breast Cancer Cell Death through Oxidative Attack and Assemblage of Pro-Apoptotic Proteins
Dibyendu Giri, Surya Kanta Dey, Sounik Manna, et al.
ACS Applied Bio Materials (2024) Vol. 7, Iss. 11, pp. 7556-7573
Closed Access | Times Cited: 3
Fibroblast Growth Factor Receptor 4 Promotes Triple‐Negative Breast Cancer Progression via Regulating Fatty Acid Metabolism Through the AKT/RYR2 Signaling
Jinhui Ye, Song Wu, Qiang Quan, et al.
Cancer Medicine (2024) Vol. 13, Iss. 23
Open Access | Times Cited: 2
Tetrahydrocurcumin targets TRIP13 inhibiting the interaction of TRIP13/USP7/c-FLIP to mediate c-FLIP ubiquitination in triple-negative breast cancer
Yujie Sun, Qiang Zhang, Shijie Cao, et al.
Journal of Advanced Research (2024)
Open Access | Times Cited: 1
YTHDF2 promotes anaplastic thyroid cancer progression by activating the DDIT4/AKT/mTOR signaling pathway
Bao Dai, Lei Xu, Shikuo Rong, et al.
Biology Direct (2024) Vol. 19, Iss. 1
Open Access | Times Cited: 1
Microenvironmental G protein‐coupled estrogen receptor‐mediated glutamine metabolic coupling between cancer‐associated fibroblasts and triple‐negative breast cancer cells governs tumour progression
Chongwu He, Meixi Peng, Xiaoqiang Zeng, et al.
Clinical and Translational Medicine (2024) Vol. 14, Iss. 12
Open Access | Times Cited: 1
Studying the effects of Saposhnikoviae Radix on the pharmacokinetic profiles of 10 bioactive compounds originating from Astragali Radix in rat plasma by UHPLC-QTRAP-MS/MS
Lin-Han Xiang, Meng-Ge Feng, Xu-Yan Guo, et al.
Journal of Ethnopharmacology (2024), pp. 118813-118813
Closed Access
Xanthine negatively regulates c‐MYC through the PI3K/AKT signaling pathway and inhibits the proliferation, invasion, and migration of breast cancer cells
Aijia Zhang, Limei Ai
Asia-Pacific Journal of Clinical Oncology (2024)
Closed Access
Receptor tyrosine kinases in breast cancer treatment: unraveling the potential
Qi Yu, Shumin Deng, Kuan-Song Wang
American Journal of Cancer Research (2024) Vol. 14, Iss. 9, pp. 4172-4196
Closed Access
Combination of Diosmetin With Chrysin Against Hepatocellular Carcinoma Through Inhibiting PI3K/AKT/mTOR/NF‐кB Signaling Pathway: TCGA Analysis, Molecular Docking, Molecular Dynamics, In Vitro Experiment
Yu Xiang, Di Zhang, Chengming Hu, et al.
Chemical Biology & Drug Design (2024) Vol. 104, Iss. 4
Closed Access
DLAT promotes triple-negative breast cancer progression via YAP1 activation
Diya Liu, Xuehui Wang, Fengyuan Qian, et al.
Cancer Biology & Therapy (2024) Vol. 25, Iss. 1
Open Access
MCM4 Promotes the Progression of Malignant Melanoma by Activating the PI3K/AKT Pathway
Xuewei Zhang, Mingming Dong, Guoxing Zheng, et al.
Environmental Toxicology (2024) Vol. 40, Iss. 2, pp. 306-317
Closed Access
The Therapeutic Effects of Bioactive Compounds on Colorectal Cancer via PI3K/Akt/mTOR Signaling Pathway: A Critical Review
Kübra Demir, Rana Turgut, Şerif Şentürk, et al.
Food Science & Nutrition (2024) Vol. 12, Iss. 12, pp. 9951-9973
Open Access
KGF secreted from HSCs activates PAK4/BMI1, promotes HCC stemness through PI3K/AKT pathway
Qing Li, Qiuyang Chen, Wenchao Wang, et al.
IUBMB Life (2024) Vol. 77, Iss. 1
Open Access
Chaperonin‐containing TCP1 subunit 6A inhibition via TRIM21‐mediated K48‐linked ubiquitination suppresses triple‐negative breast cancer progression through the AKT signalling pathway
Mengdi Yang, Jianing Cao, Tiantian Liu, et al.
Clinical and Translational Medicine (2024) Vol. 14, Iss. 11
Open Access
Identifying therapeutic strategies for triple-negative breast cancer via phosphoproteomics
Yuhan Sheng, Gordon B. Mills, Xuejiao Zhao
Expert Review of Proteomics (2024), pp. 1-17
Closed Access
Page 1 - Next Page

Scroll to top